Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04315506 · ClinicalTrials.gov registry record · NA
A Text-based Reduction Intervention for Smokeless Tobacco Cessation
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 532
- Enrollment target
NCT04315506: Completed NA study, sponsored by Duke University.
NCT04315506 is a NA study that has completed, run by Duke University. The registered enrollment target is 532 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (62% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04315506, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 532 participants
- Enrollment target
Study Summary
Participants will be randomly assigned (like the flip of a coin) to one of the two groups after completing the baseline survey. Participants have a 50% of being in either the #EnufSnuff.TXT intervention group or the Enough Snuff Intervention group. Participants will then be given a baseline survey and the intervention will be explained to them.
Primary Outcome
Measured by self-report. Number of participants who replied "no" the following: "In the past 7 days, have you used chew/dip?- Yes or No".
Interventions
- BEHAVIORAL #EnufSnuff.TXT Intervention
- BEHAVIORAL Enough Snuff Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 532 participants |
| Start Date | 2020-10-16 |
| Est. Completion | 2023-01-28 |
| Phase | NA |
What the finished NCT04315506 record still lists
NCT04315506 is an interventional study that assigns participants to a tested intervention. The registered 532 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (62% lower).
The record links to 0 conditions, and to 2 interventions - of which #EnufSnuff.TXT Intervention is the first listed.
NCT04315506 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04315506 about?
NCT04315506 is a clinical study titled "A Text-based Reduction Intervention for Smokeless Tobacco Cessation". Participants will be randomly assigned (like the flip of a coin) to one of the two groups after completing the baseline survey. Participants have a 50% of being in either the #EnufSnuff.TXT intervention group or the Enough Snuff Intervention group. Participants will then be given a baseline survey a...
What is the current status of trial NCT04315506?
This trial is currently completed. It is a NA study. The enrollment target is 532 participants. The study started on 2020-10-16. Estimated completion is 2023-01-28.
What interventions are being tested in trial NCT04315506?
The interventions under investigation include: #EnufSnuff.TXT Intervention (BEHAVIORAL), Enough Snuff Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04315506?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04315506's enrollment target sits among peer trials
532 188th of 2000 higher than 1,813 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05793151 · 532 participants · NA
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
- NCT06378866 · 532 participants · Phase 2
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
- NCT07219173 · 531 participants · Phase 2
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- NCT04910685 · 534 participants · Phase 2
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI